At the forefront of innovation 

The general objective of the project is the development of a new vaccine against antibiotic multiresistant extraintestinal pathogenic E. coli, causing of recurrent cystitis, seeking for both a systemic and mucosal protection against the infection. This vaccine should protect also at the level of the urinary mucosa, preventing adhesion and bacterial colonization.